94399 ⎘
Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms Radicals substituted by nitrogen atoms not forming part of a nitro radical
METHODS AND MATERIALS FOR INCREASING LEVEL OF PHOSPHORYLATED AMPK PROTEIN
#2POURABLE WETTING AGENTS AND METHODS ASSOCIATED THEREWITH
#3PHENTOLAMINE MESYLATE AND THERAPEUTIC USES THEREOF
#4CLAUDIN INHIBITORS AND METHODS OF USE THEREOF
#5MERCAPTOACETOPHENONE AMINOHYDRAZONES, THEIR SALTS AND USES THEREOF
#6HIGHLY PURE PHENTOLAMINE MESYLATE AND METHODS FOR MAKING SAME
#7PHENYL CYCLOHEXANONE DERIVATIVES AND METHODS OF MAKING AND USING THEM
#8Highly pure phentolamine mesylate
#9Highly pure phentolamine mesylate and methods for making same
#10Chemical products for surface protection
#11METHODS AND MATERIALS FOR INCREASING LEVEL OF PHOSPHORYLATED AMPK PROTEIN
#12SMALL MOLECULES TARGETING MUTANT MAMMALIAN PROTEINS
#13Phenyl cyclohexanone derivatives and methods of making and using them
#142- or 3-imidazolines as carbapenemases inhibitors
#15Chemical products for surface protection
#16Phenyl cyclohexanone derivatives and methods of making and using them
#17Phenyl imidazoline compound having aminomethyl group or salt thereof, or phenyl tetrahydropyrimidine compound having aminomethyl group or salt thereof, and production method for such compounds or salts thereof
#18Intracellular delivery vehicle
#19Emulsifiers for Invert Emulsion Drilling Fluids
#20Dual functioning corrosion inhibitor and foaming agent
#21Intracellular delivery vehicle
#22Amide compound, methods for preparation, and use thereof as agent for the treatment and prevention of diseases caused by rna- and/or dna-containing viruses, and concomitant diseases
#23Synthesis of copanlisib and its dihydrochloride salt
#24Blood brain barrier-penetrating oximes for cholinesterase reactivation
#254,5-DIAMINOIMIDAZOLES AS NOVEL DEVELOPER-TYPE OXIDATION DYE PRECURSORS
#26AMIDE COMPOUNDS, METHODS FOR PREPARATION, AND USE THEREOF AS AGENTS FOR THE TREATMENT AND PREVENTION OF DISEASES CAUSED BY RNA- AND/OR DNA-CONTAINING VIRUSES, AND CONCOMITANT DISEASES
#27Fatty amides and derivatives from natural oil metathesis
#28Prostamides for the treatment of glaucoma and related diseases
#29Chemical products for surface protection
#30Antibacterial compounds targeting isoprenoid biosynthesis
#31Imidazoline amides and derivitives from natural oil metathesis
#32Polyamide hardeners for epdxy resins
#33Apoptosis promoters
#34Prostamides for the treatment of glaucoma and related diseases
#35Blood brain barrier-penetrating oximes for cholistenerases reactivation
#36Drug targets to overcome de novo drug-resistance in multiple myeloma
#37Apoptosis promoters
#38Omega-aminoalkylamides of R-2-aryl-propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells
#39Substituted imidazole derivates
#40Imidazole derivatives and their use as modulators of cyclin dependent kinases
#41Sphingosine kinase inhibitors
#42Method for producing biofuel using marine algae-derived galactan
#43Substituted imidazole derivatives and methods of use thereof for treating cancer
#44Nuclear export inhibitors of topoisomerase II alpha
#45Apoptosis promoters
#46IMIDAZOLINYLMETHYL ARYL SULFONAMIDE
#47IMIDAZOLINYLMETHYL ARYL SULFONAMIDE
#48Apoptosis promoters
#494-(phenyl-piperazinyl-methyl)benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
#50TRYPHOSTIN-ANALOGS FOR THE TREATMENT OF CELL PROLIFERATIVE DISEASES
#515-Membered heterocyclic compound
#52Inhibitors for the soluble epoxide hydrolase
#53N-(2-arylethyl)benzylamines as antagonists of the 5-HT6 receptor
#54Thiosemicarbazones as anti-virals and immunopotentiators
#55Substituted imidazole derivatives
#56Insecticidal Substituted Aminoalkyl Heterocyclic and Heteroaryl Derivatives
#57IMIDAZOLINYLMETHYL ARYL SULFONAMIDE
#58IMIDAZOLINYLMETHYL ARYL SULFONAMIDE
#59IMIDAZOLINYLMETHYL ARYL SULFONAMIDE
#60Imidazolinylmethyl aryl sulfonamide
#61Methods of treating cancer with imidazolyl compounds
#625-Membered heterocyclic compound
#6311-Beta-Hydroxysteroid Dehydrogenase Inhibitors
#642-imidazolines
#654-imidazolines
#66Pesticidal heterocycles
#67Bifunctional synthetic molecules
#68Compound and Methods For the Treatment of Cancer and Malaria
#69Ion Channel Modulators
#70Bisbenzamidines for the Treatment of Pneumonia
#71Sphingosine kinase inhibitors
#72Heterocyclic compounds as P2X7 ion channel blockers
#73OMEGA-AMINOALKYLAMIDES OF R-2-ARYL-PROPIONIC ACIDS AS INHIBITORS OF THE CHEMOTAXIS OF POLYMORPHONUCLEATE AND MONONUCLEATE CELLS
#74Prostamides for the treatment of glaucoma and related diseases
#75Compounds
#76Melanin concentrating hormone antagonist
#77Asphaltene dispersants for petroleum products
#78N-(2-ARYLETHYL)BENZYLAMINES AS ANTAGONISTS OF THE 5-HT6 RECEPTOR
#79Apoptosis promoters
#80Polymerisation initiator system
#81Substituted N-cinnamyl benzamides
#82Sphingosine kinase inhibitors
#83Cis-imidazolines
#84Ureas as factor Xa inhibitors
#85Thioureas as factor Xa inhibitors
#862-(Bicyclo)alkylamino-derivatives as mediators of chronic pain and inflammation
#87Amine derivative
#88Substituted biaryl-carboxylate derivatives
#89Bradykinin-B1 antagonists, process for their preparation and their use as medicaments
#90N-(2-Arylethyl) benzylamines as antagonists of the 5-HTreceptor
#91Substituted imidazole derivatives
#92Serine protease inhibitors
#93Nitrosated and nitrosylated alpha-adrenergic receptor antagonist compounds
#94Inhibitors for the soluble epoxide hydrolase
#95Pesticidal heterocycles
#96Amide compounds and methods of using the same
#97Omega aminoalkylamides of R-2 aryl propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells
#98Thiosemicarbazones as anti-virals and immunopotentiators
#99Nitrosated and nitrosylated alpha-adrenergic receptor antagonist compounds, compositions and their uses
#100Methods and compositions for the treatment of amyloid-and epileptogenesis-associated diseases
#101Heterocyclic compounds as P2X7 ion channel blockers
#102Inhibitors for the soluble epoxide hydrolase
#103N-heteroarylmethyl-p-phenylenediamine derivatives as well as oxidation dyeing agents containing these compounds